Laura van ‘t Veer, PhD
Professor, Laboratory Medicine, UCSF

Laura is a world-renowned Molecular Biologist, and Leader of the Breast Oncology Program and Associate Director Applied Genomics at the HDFCCC. She is the former Head of Diagnostic Oncology of the Netherlands Cancer Institute, and inventor of MammaPrint. Her research focuses on personalized medicine, and aims to advance patient management based on knowledge of the genetic makeup of the tumor as well as the genetic makeup of the patient. Laura is the UCSF Precision Medicine Platform convener for cancer, and she chairs the Biomolecular Committee of the I-SPY 2 trial ensuring CLIA compliant companion diagnostics. She is also the Principal Investigator of the Athena Breast Health Network at UCSF, a 150,000-women cohort study evaluating new paradigms to enhance breast health.